In mice, obesity-related inflammation causes an increase in IL-1β production, which then promotes angiogenesis and tumor progression by upregulating Angptl4, thereby setting the rationale for future exploitation of this factor as a potential therapeutic target for obese breast cancer patients [129]. The gene discussed is ANGPTL4; the disease is obesity due to melanocortin 4 receptor deficiency.